[go: up one dir, main page]

EA200001184A1 - Фенилсульфонамидфенилэтиламины, полезные в качестве допаминовых рецепторов - Google Patents

Фенилсульфонамидфенилэтиламины, полезные в качестве допаминовых рецепторов

Info

Publication number
EA200001184A1
EA200001184A1 EA200001184A EA200001184A EA200001184A1 EA 200001184 A1 EA200001184 A1 EA 200001184A1 EA 200001184 A EA200001184 A EA 200001184A EA 200001184 A EA200001184 A EA 200001184A EA 200001184 A1 EA200001184 A1 EA 200001184A1
Authority
EA
Eurasian Patent Office
Prior art keywords
alkyl
sulphonamidphenylethylamines
phenyl
useful
dopamine receptors
Prior art date
Application number
EA200001184A
Other languages
English (en)
Other versions
EA002918B1 (ru
Inventor
Артур Гленн Ромеро
Джеффри А. Лейби
Original Assignee
Фармация Энд Апджон Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармация Энд Апджон Компани filed Critical Фармация Энд Апджон Компани
Publication of EA200001184A1 publication Critical patent/EA200001184A1/ru
Publication of EA002918B1 publication Critical patent/EA002918B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Раскрываются соединения формулы I и их фармацевтически приемлемые соли, обладающие селективной активностью D3 допаминовых рецепторов, подходящие для лечения расстройств центральной нервной системы. Формула IRнезависимо представляет H или C-Cалкил, включая его изомерные формы;Rпредставляет H, C-Cалкил, галоген, OCH, OCF, CF, CN, SCHили NHCOCH; иRпредставляет H, C-Cалкил, галоген, OCH, OCF, CF, CN, SCHили NHCOCH.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200001184A 1998-05-14 1999-05-07 Производные фенилсульфонамидфенилэтиламина и их применение в качестве допаминовых рецепторов EA002918B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8549398P 1998-05-14 1998-05-14
PCT/US1999/007023 WO1999058499A1 (en) 1998-05-14 1999-05-07 Phenylsulfonamide-phenylethylamines useful as dopamine receptors

Publications (2)

Publication Number Publication Date
EA200001184A1 true EA200001184A1 (ru) 2001-04-23
EA002918B1 EA002918B1 (ru) 2002-10-31

Family

ID=22191975

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200001184A EA002918B1 (ru) 1998-05-14 1999-05-07 Производные фенилсульфонамидфенилэтиламина и их применение в качестве допаминовых рецепторов

Country Status (24)

Country Link
US (1) US6103766A (ru)
EP (1) EP1077935B1 (ru)
JP (1) JP2002514623A (ru)
KR (1) KR20010043546A (ru)
CN (1) CN1152857C (ru)
AT (1) ATE253045T1 (ru)
AU (1) AU752543B2 (ru)
BR (1) BR9910405A (ru)
CA (1) CA2327345A1 (ru)
DE (1) DE69912419T2 (ru)
DK (1) DK1077935T3 (ru)
EA (1) EA002918B1 (ru)
ES (1) ES2211078T3 (ru)
HU (1) HUP0101746A3 (ru)
IL (1) IL139263A0 (ru)
NO (1) NO20005732D0 (ru)
NZ (1) NZ508152A (ru)
PL (1) PL343891A1 (ru)
PT (1) PT1077935E (ru)
SK (1) SK16242000A3 (ru)
TR (1) TR200003325T2 (ru)
TW (1) TW450954B (ru)
WO (1) WO1999058499A1 (ru)
ZA (1) ZA200005921B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225960B1 (en) * 1997-02-27 2008-01-28 Takeda Pharmaceutical Amine compounds, their production and use
US6849635B2 (en) * 2001-05-07 2005-02-01 Smithkline Beecham Corporation Sulfonamides
US20050043536A1 (en) * 2001-05-07 2005-02-24 Dashyant Dhanak Sulfonamides
CA2583983C (en) * 2004-10-14 2013-07-16 Abbott Gmbh & Co. Kg Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
EP1809597B1 (en) 2004-10-14 2012-01-11 Abbott GmbH & Co. KG Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
CA2583333C (en) 2004-10-14 2013-05-14 Abbott Gmbh & Co. Kg Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
CN101421243B (zh) * 2006-04-14 2012-05-30 艾博特股份有限两合公司 适用于治疗对多巴胺d3受体调节有反应的病症的芳氧基乙胺化合物
US8383641B2 (en) 2006-04-14 2013-02-26 Abbott Gmbh & Co. Kg Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
AR060526A1 (es) 2006-04-19 2008-06-25 Abbott Gmbh Compuestos heterociclicos para tratar trastornos que responden a la modulacion del receptor de serotonina 5ht6
TW200808762A (en) 2006-04-19 2008-02-16 Abbott Gmbh & Co Kg Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor
WO2008026046A1 (en) * 2006-08-30 2008-03-06 Pfizer Products Inc. Morpholine d3 dopamine antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574741A (en) * 1969-04-14 1971-04-13 Mead Johnson & Co Sulfonamidophenalkylamines
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
GB9402197D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Compounds
AU4368996A (en) * 1994-11-23 1996-06-17 Neurogen Corporation Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
CA2253927A1 (en) * 1996-05-11 1997-11-20 Smithkline Beecham P.L.C. Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
WO1998003473A1 (en) * 1996-07-22 1998-01-29 Novo Nordisk A/S Compounds with growth hormone releasing properties
JPH1180156A (ja) * 1997-09-04 1999-03-26 Hokuriku Seiyaku Co Ltd １−（置換アリール）アルキル−１ｈ−イミダゾピリジン−４−アミン誘導体

Also Published As

Publication number Publication date
JP2002514623A (ja) 2002-05-21
HUP0101746A2 (hu) 2002-03-28
EP1077935B1 (en) 2003-10-29
CN1152857C (zh) 2004-06-09
WO1999058499A1 (en) 1999-11-18
AU3741899A (en) 1999-11-29
NO20005732L (no) 2000-11-13
NZ508152A (en) 2003-03-28
BR9910405A (pt) 2001-01-09
US6103766A (en) 2000-08-15
DK1077935T3 (da) 2004-02-16
PL343891A1 (en) 2001-09-10
KR20010043546A (ko) 2001-05-25
NO20005732D0 (no) 2000-11-13
HUP0101746A3 (en) 2002-10-28
ES2211078T3 (es) 2004-07-01
ATE253045T1 (de) 2003-11-15
IL139263A0 (en) 2001-11-25
PT1077935E (pt) 2004-03-31
ZA200005921B (en) 2001-11-14
EA002918B1 (ru) 2002-10-31
DE69912419D1 (de) 2003-12-04
EP1077935A1 (en) 2001-02-28
DE69912419T2 (de) 2004-07-22
SK16242000A3 (sk) 2001-06-11
TR200003325T2 (tr) 2001-04-20
TW450954B (en) 2001-08-21
HK1036049A1 (en) 2001-12-21
CA2327345A1 (en) 1999-11-18
AU752543B2 (en) 2002-09-19
CN1297431A (zh) 2001-05-30

Similar Documents

Publication Publication Date Title
HUT62861A (en) Composition with fungicidal activity, comprising carboxylic acid anilide derivative as active ingredient, its application, as well as process for producing the active ingredients
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
EA200000481A1 (ru) Производные гидроксамовой кислоты в качестве ингибиторов металлопротеаз матрикса (мпм)
SE8500368D0 (sv) Heterocykliska foreningar
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
EA200200873A1 (ru) Новые пиперазиновые производные
EA200201141A1 (ru) Производные тропана, полезные для терапии
UY25230A1 (es) Derivados de la d-prolina
EA200001184A1 (ru) Фенилсульфонамидфенилэтиламины, полезные в качестве допаминовых рецепторов
ES538418A0 (es) Un derivado de indol-3-carboxamida
NO165343C (no) Analogifremgangsmaate til fremstilling av nye, terapeutiskaktive 3-(2-aminoetyl)indoler.
PE75199A1 (es) Derivado de quinolina util como antagonista de neuroquinina
EA200301143A1 (ru) Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6
RO82956A (ro) Procedeu pentru prepararea unor derivati de benzamida
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
CY1108837T1 (el) ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5
DK1254905T3 (da) 4-(2-pyridyl)piperiziner med 5HT7 receptoragonistaktivitet
FI962768A0 (fi) N-(2-ftaali-imidoetyyli)substituoituja transpiperidiini-2,5-dikarboksylaatteja
EA199900043A1 (ru) ПРОИЗВОДНЫЕ ПИРИДИЛКАРБАМОИЛИНДОЛИНОВ В КАЧЕСТВЕ АНТАГОНИСТОВ 5-НТ2с-РЕЦЕПТОРОВ
EA200401099A1 (ru) Производные гетероциклического амида
DE69123757D1 (de) Epoxysuccinamidsäurederivat
EA199900836A1 (ru) Противосудорожные производные изохинолилбензамида
ES555991A0 (es) Procedimiento para la obtencion de derivados de benzaldoxim-carbamato
EA200100033A1 (ru) Тетрагидронафтиридинил-карбоксамиды, обладающие противосудорожной активностью
ATE238300T1 (de) (3,4-dihydro-2h-benzo(1,4)oxazinyl-methyl)-3-(1 - indol-3-yl)-alkylamine

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU